Randall Carlson & Graham Hancock.

"Interest in the therapeutic potential of psychedelics, having lain relatively dormant in the face of stigma and heavy regulations for decades, has reignited in the last ten years. Landmark studies showing these compounds’ effectiveness in treating some mood disorders have kick started a wave of clinical research, with well over 100 separate trials now investigating psychedelics’ health applications." https://www.technologynetworks.com/neuroscience/articles/an-introduction-to-five-psychedelics-psilocybin-dmt-lsd-mdma-and-ketamine-355897 reply

Anyone know the original air date of this podcast episode? reply

I’ve listened to this at least 5 times 👍🏼👍🏼👍🏼👍🏼 reply